Drug Profile
Research programme: opioid delta receptor agonists - Nippon Chemiphar
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nippon Chemiphar
- Class Opioid analgesics
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in Japan
- 31 Mar 2013 Early research in Pain in Japan